CTRI/2021/12/039065已完成4 期
PrescRiption Event MOnitoring for Ferric CarboxyMaltose in Management of Anemia in Indian Real Life ScEnario. (PROMISE) - PROMISE
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 1,800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. Patients with iron deficiency anemia who received Ferric carboxymaltose injection (Orofer FCM) 500/1000 mg in clinical practice as per the locally approved prescribing information and treating physician is ready to share anonymized data of such patients, will be included.
- •2. Data for hematological parameters (hemoglobin, serum ferritin) are available at baseline and/or for minimum at 4 Ã?± 1 weeks.
排除标准
- •1. Any other type of anemia apart from iron deficiency anemia.
- •2. Severe iron deficiency anemia with hemoglobin < 4 g/dL
- •3. Evidence of iron overload conditions (e.g. hemochromatosis/hemosiderosis).
- •4. Any malignancy.
- •5. Any condition that, in the opinion of the investigator, does not justify the patientââ?¬•s inclusion in the study.
研究者
相似试验
尚未招募
4 期
To evaluate the safety and efficacy of Emrok tablet and Emrok Injection by the surveillance study.CTRI/2023/09/057485Wockhardt Ltd
尚未招募
4 期
Real world study to evaluate the safety and efficacy of NUWOK tab and Injection in the patients have infection.CTRI/2024/04/065903Wockhardt Ltd
尚未招募
4 期
Prescription event monitoring study of Emrok injection and tabin the patient of diabetes foot ulcer.CTRI/2024/04/065615Wockhardt Ltd
进行中（未招募）
不适用
Intravenous ferric carboxymaltose (Ferinject®) with or without Erythropoietin for the correction of preoperative anaemia in patients undergoing orthopaedic surgery•To evaluate the effect of the administration of ferric carboxymaltose (Ferinject®) with or without erythropoietin vs. no treatment (standard therapy) on the preoperative anaemia status in patients undergoing orthopaedic surgery •To gain informations for the design of a possible follow-up study•.•To evaluate the tolerability and safety of Ferinject®EUCTR2009-015799-92-ATniversitätspital Zürich Anästhesie75
终止
2 期
Iron Infusion in Heart Failure StudyIron DeficiencyCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemChronic Heart FailureACTRN12615000952549Professor Andrew Sindone82